Treatment outcome in children with nontuberculous mycobacterial lymphadenitis: A retrospective follow-up study

Introduction: Information on the long-term treatment outcome following nontuberculous mycobacterial (NTM) lymphadenitis is very limited. We performed a study to (a) compare cure rates following different initial treatment courses, (b) describe subsequent treatment courses and their outcomes, and (c)...

Full description

Bibliographic Details
Main Authors: Annicka Reuss, Sarah Drzymala, Barbara Hauer, Rüdiger von Kries, Walter Haas
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:International Journal of Mycobacteriology
Subjects:
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=1;spage=76;epage=82;aulast=Reuss
id doaj-196584d3482f48658232878ea323b077
record_format Article
spelling doaj-196584d3482f48658232878ea323b0772020-11-24T23:43:14ZengWolters Kluwer Medknow PublicationsInternational Journal of Mycobacteriology2212-55312212-554X2017-01-0161768210.4103/2212-5531.201898Treatment outcome in children with nontuberculous mycobacterial lymphadenitis: A retrospective follow-up studyAnnicka ReussSarah DrzymalaBarbara HauerRüdiger von KriesWalter HaasIntroduction: Information on the long-term treatment outcome following nontuberculous mycobacterial (NTM) lymphadenitis is very limited. We performed a study to (a) compare cure rates following different initial treatment courses, (b) describe subsequent treatment courses and their outcomes, and (c) determine the occurrence of late sequelae in immunocompetent children with NTM lymphadenitis. Materials and Methods: In 2011, we conducted a retrospective follow-up study in 71 parents whose children had been hospitalized with NTM disease 2002–2005. A telephone survey was performed using a standardized questionnaire to collect information on the therapeutic management and treatment outcome. Results: Of 61 children with NTM lymphadenitis, 33 (54%) children were cured after the initial treatment. We found no significant difference in cure rates following surgical intervention only (45%, 13/29 children) and a combination of surgical intervention and chemotherapy (61%, 19/31 children). In 7 out of 11 children, the cure rate following complete lymph node excision was 64%. Subsequent courses of treatment including repeated surgical intervention, combination therapy, chemotherapy only, and wait-and-see strategy in children where initial therapy failed resulted in the cure of all 61 children. In four children (7%), recurrences were observed up to 5 years later. Conclusions: Our study showed that recurrent NTM lymphadenitis might be observed several years after initial resolution of disease. The cure rate following complete lymph node excision was lower than reported in other studies. Subsequent treatment courses were necessary in half of the children. Physicians and parents need to be aware that NTM lymphadenitis in children requires careful choice of intervention and active follow-up.http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=1;spage=76;epage=82;aulast=ReussAntimycobacterial drugsethambutolGermanyimmunocompromised patientsnontuberculous mycobacterial lymphadenitisrifamycin
collection DOAJ
language English
format Article
sources DOAJ
author Annicka Reuss
Sarah Drzymala
Barbara Hauer
Rüdiger von Kries
Walter Haas
spellingShingle Annicka Reuss
Sarah Drzymala
Barbara Hauer
Rüdiger von Kries
Walter Haas
Treatment outcome in children with nontuberculous mycobacterial lymphadenitis: A retrospective follow-up study
International Journal of Mycobacteriology
Antimycobacterial drugs
ethambutol
Germany
immunocompromised patients
nontuberculous mycobacterial lymphadenitis
rifamycin
author_facet Annicka Reuss
Sarah Drzymala
Barbara Hauer
Rüdiger von Kries
Walter Haas
author_sort Annicka Reuss
title Treatment outcome in children with nontuberculous mycobacterial lymphadenitis: A retrospective follow-up study
title_short Treatment outcome in children with nontuberculous mycobacterial lymphadenitis: A retrospective follow-up study
title_full Treatment outcome in children with nontuberculous mycobacterial lymphadenitis: A retrospective follow-up study
title_fullStr Treatment outcome in children with nontuberculous mycobacterial lymphadenitis: A retrospective follow-up study
title_full_unstemmed Treatment outcome in children with nontuberculous mycobacterial lymphadenitis: A retrospective follow-up study
title_sort treatment outcome in children with nontuberculous mycobacterial lymphadenitis: a retrospective follow-up study
publisher Wolters Kluwer Medknow Publications
series International Journal of Mycobacteriology
issn 2212-5531
2212-554X
publishDate 2017-01-01
description Introduction: Information on the long-term treatment outcome following nontuberculous mycobacterial (NTM) lymphadenitis is very limited. We performed a study to (a) compare cure rates following different initial treatment courses, (b) describe subsequent treatment courses and their outcomes, and (c) determine the occurrence of late sequelae in immunocompetent children with NTM lymphadenitis. Materials and Methods: In 2011, we conducted a retrospective follow-up study in 71 parents whose children had been hospitalized with NTM disease 2002–2005. A telephone survey was performed using a standardized questionnaire to collect information on the therapeutic management and treatment outcome. Results: Of 61 children with NTM lymphadenitis, 33 (54%) children were cured after the initial treatment. We found no significant difference in cure rates following surgical intervention only (45%, 13/29 children) and a combination of surgical intervention and chemotherapy (61%, 19/31 children). In 7 out of 11 children, the cure rate following complete lymph node excision was 64%. Subsequent courses of treatment including repeated surgical intervention, combination therapy, chemotherapy only, and wait-and-see strategy in children where initial therapy failed resulted in the cure of all 61 children. In four children (7%), recurrences were observed up to 5 years later. Conclusions: Our study showed that recurrent NTM lymphadenitis might be observed several years after initial resolution of disease. The cure rate following complete lymph node excision was lower than reported in other studies. Subsequent treatment courses were necessary in half of the children. Physicians and parents need to be aware that NTM lymphadenitis in children requires careful choice of intervention and active follow-up.
topic Antimycobacterial drugs
ethambutol
Germany
immunocompromised patients
nontuberculous mycobacterial lymphadenitis
rifamycin
url http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=1;spage=76;epage=82;aulast=Reuss
work_keys_str_mv AT annickareuss treatmentoutcomeinchildrenwithnontuberculousmycobacteriallymphadenitisaretrospectivefollowupstudy
AT sarahdrzymala treatmentoutcomeinchildrenwithnontuberculousmycobacteriallymphadenitisaretrospectivefollowupstudy
AT barbarahauer treatmentoutcomeinchildrenwithnontuberculousmycobacteriallymphadenitisaretrospectivefollowupstudy
AT rudigervonkries treatmentoutcomeinchildrenwithnontuberculousmycobacteriallymphadenitisaretrospectivefollowupstudy
AT walterhaas treatmentoutcomeinchildrenwithnontuberculousmycobacteriallymphadenitisaretrospectivefollowupstudy
_version_ 1725502507761795072